U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07336459) titled 'AI-Driven MRF Type 2 Diabetes Integrating DHT IF and Resistance Training to OM and Functional Outcomes' on Nov. 21, 2025.
Brief Summary: This randomized controlled trial aims to evaluate the effectiveness of an AI-driven multimodal rehabilitation framework combining digital health technologies, intermittent fasting, and resistance training in individuals with Type 2 Diabetes Mellitus (T2DM). The study will integrate mobile-based AI monitoring for glucose trends, physical activity tracking, and dietary adherence reminders, thereby improving patient engagement and self-management.
Study Start Date: April 17, 2025
Study Type: INTERVE...